SG Americas Securities’s NEVRO CORP. NVRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-55,390
| Closed | -$323K | – | 3740 |
|
|
2025
Q1 | $323K | Buy |
55,390
+38,264
| +223% | +$202K | ﹤0.01% | 2149 |
|
|
2024
Q4 | $64K | Buy |
17,126
+4,406
| +35% | +$20.3K | ﹤0.01% | 2860 |
|
|
2024
Q3 | $71K | Buy |
+12,720
| New | +$89K | ﹤0.01% | 3169 |
|
|
2023
Q4 | – | Sell |
-14,256
| Closed | -$274K | – | 3505 |
|
|
2023
Q3 | $274K | Buy |
+14,256
| New | +$304K | ﹤0.01% | 2128 |
|
|
2023
Q1 | – | Sell |
-4,155
| Closed | -$165K | – | 3612 |
|
|
2022
Q4 | $165K | Sell |
4,155
-4,729
| -53% | -$197K | ﹤0.01% | 2347 |
|
|
2022
Q3 | $414K | Buy |
8,884
+5,289
| +147% | +$245K | 0.01% | 1716 |
|
|
2022
Q2 | $158K | Sell |
3,595
-23,339
| -87% | -$1.28M | ﹤0.01% | 2840 |
|
|
2022
Q1 | $1.95M | Sell |
26,934
-5,475
| -17% | -$395K | 0.01% | 936 |
|
|
2021
Q4 | $2.63M | Buy |
32,409
+16,436
| +103% | +$1.65M | 0.01% | 874 |
|
|
2021
Q3 | $1.86M | Buy |
15,973
+4,855
| +44% | +$635K | 0.01% | 1336 |
|
|
2021
Q2 | $1.84M | Buy |
11,118
+3,702
| +50% | +$578K | 0.01% | 1178 |
|
|
2021
Q1 | $1.03M | Buy |
7,416
+2,383
| +47% | +$389K | 0.01% | 1518 |
|
|
2020
Q4 | $871K | Sell |
5,033
-6,038
| -55% | -$978K | ﹤0.01% | 1614 |
|
|
2020
Q3 | $1.54M | Sell |
11,071
-431
| -4% | -$57.6K | 0.01% | 924 |
|
|
2020
Q2 | $1.37M | Sell |
11,502
-7,080
| -38% | -$840K | 0.01% | 1111 |
|
|
2020
Q1 | $1.86M | Buy |
18,582
+17,000
| +1,075% | +$2.04M | 0.02% | 851 |
|
|
2019
Q4 | $186K | Sell |
1,582
-5,381
| -77% | -$533K | ﹤0.01% | 2532 |
|
|
2019
Q3 | $599K | Sell |
6,963
-23,435
| -77% | -$1.77M | ﹤0.01% | 1767 |
|
|
2019
Q2 | $1.97M | Buy |
30,398
+21,842
| +255% | +$1.36M | 0.01% | 1019 |
|
|
2019
Q1 | $535K | Sell |
8,556
-41,609
| -83% | -$1.96M | ﹤0.01% | 1786 |
|
|
2018
Q4 | $1.95M | Buy |
+50,165
| New | +$2.23M | 0.02% | 891 |
|
|
2018
Q3 | – | Sell |
-1,792
| Closed | -$143K | – | 3507 |
|
|
2018
Q2 | $143K | Sell |
1,792
-608
| -25% | -$50.4K | ﹤0.01% | 2838 |
|
|
2018
Q1 | $208K | Buy |
+2,400
| New | +$194K | ﹤0.01% | 2412 |
|
|
2017
Q3 | – | Sell |
-1,427
| Closed | -$106K | – | 3776 |
|
|
2017
Q2 | $106K | Sell |
1,427
-787
| -36% | -$63K | ﹤0.01% | 2882 |
|
|
2017
Q1 | $207K | Buy |
2,214
+542
| +32% | +$49.1K | ﹤0.01% | 2411 |
|
|
2016
Q4 | $121K | Sell |
1,672
-619
| -27% | -$53K | ﹤0.01% | 2739 |
|
|
2016
Q3 | $239K | Buy |
+2,291
| New | +$207K | ﹤0.01% | 2339 |
|
Other funds holding NVRO
SG Americas Securities's NVRO Position: Q2 2025 in Review
SG Americas Securities sold out of NEVRO CORP. (NVRO) in Q2 2025, closing a stake of 55,390 shares — an estimated $323K sold.
SG Americas Securities first reported a position in NVRO in Q3 2016 and held it in 27 quarters. The position peaked at $2.63M in Q4 2021. 1 fund tracked by Wall St. Rank holds NVRO as of Q2 2025.
- SG Americas Securities reported no remaining NEVRO CORP. position as of Q2 2025 after selling out during the quarter.
- SG Americas Securities sold 55,390 NEVRO CORP. shares in Q2 2025, an estimated $323K.
- SG Americas Securities first reported a position in NEVRO CORP. in Q3 2016 and held it in 27 quarters.
- SG Americas Securities's NEVRO CORP. position peaked at $2.63M in Q4 2021.
- 1 fund tracked by Wall St. Rank held NEVRO CORP. as of Q2 2025.
Based on SG Americas Securities's 13F filing for Q2 2025, filed 8 Aug 2025.